NCT00279084 NEPHRODIAB2 Prospective Randomized Controlled Open-Labelled Trial Comparing Effect of Two Haemoglobin Levels Status UNKNOWN Phase NA
NCT00267514 Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis Patients Status COMPLETED Phase PHASE3
NCT00242164 Defining The Role Of Dialysate Magnesium In Arrhythmogenicity On Dialysis Status COMPLETED Phase PHASE2
NCT00238043 Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia Status UNKNOWN Phase PHASE3
NCT00231803 The Canadian Prevention of Renal and Cardiovascular Endpoints Trial Status COMPLETED Phase NA
NCT00228436 Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients Status COMPLETED Phase PHASE2
NCT00212875 A Study of Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Status COMPLETED Phase PHASE2
NCT00196755 Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal Dialysis Status COMPLETED Phase PHASE3
NCT00194961 Effect of Growth Hormone on Leptin, Cytokines and Body Composition of Children With Growth Failure Due to Chronic Kidney Disease Status TERMINATED Phase PHASE4
NCT00190580 Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease Status COMPLETED Phase PHASE4
NCT00184769 Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation. Status COMPLETED Phase PHASE4
NCT00184652 Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease Status COMPLETED Phase PHASE2
NCT00169923 Anti-Inflammatory Effects of Rosiglitazone in Patients With Stage 4 and 5 Chronic Kidney Disease Status WITHDRAWN Phase PHASE2/PHASE3
NCT00156962 Epoetin Alfa (EPO) in Subjects With Chronic Kidney Disease (CKD) Status TERMINATED Phase PHASE3